NEW! Investment Companies Centre

American Express Platinum Cashback Card:

Mylan Labs Inc. (MYL)

Sector:

Medicine and Biotech Research

Index:

S&P 500

Market Cap

$2,955.48m

Change Today

Price Up$0.34 (3.63%)

Share Price

$9.71

Mylan Labs Inc. Overview

Mylan is a leading generic and specialty pharmaceutical company whose products are used in areas including cardiovascular, central nervous system, dermatology and gastrointestinal. The Pennsylvania-based business was set up in 1961.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Income & Efficiency

Latest F'cast
Div Yield 0.8% 1.9%
Div Cover -74.8 3.6
Op Mrgn -45.4% 6.4%
ROCE -76.9%  

Valuation

Latest F'cast
P/E n/a 15.4
PEG n/a n/a
Pr/Revenue 1.0 0.6
Pr/Book 0.9  

Growth

Latest F'cast
Revenue 79.4% 112.9%
PBT n/a n/a
EPS n/a n/a
DPS -66.8% 121.8%

Mylan Labs Inc. Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-04 1,374.62 512.61 124.00¢ 37.0 1.4 +26% 10.00¢ 0.2%
31-Mar-05 1,253.37 312.25 76.00¢ 47.9 n/a -39% 12.00¢ 0.3%
31-Mar-06 1,257.16 274.61 80.00¢ 29.2 5.8 +5% 24.00¢ 1.0%
31-Mar-07 1,611.82 425.51 101.00¢ 20.9 0.8 +26% 24.00¢ 1.1%
31-Dec-07 2,178.76 (1,081.06) (595.95)¢ n/a n/a n/a 7.96¢ 0.6%

Mylan Labs Inc. Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-08 4,639.58 295.68 63.06¢ 15.4 n/a n/a 17.67¢ 1.9%
31-Dec-09 5,090.95 588.37 98.35¢ 9.9 0.2 +56% 13.00¢ 1.4%

Covering analysts: Argus Research, Bank of America Securities, Barclays Capital, Bernstein Research, Caris & Company, Credit Suisse, Goldman Sachs, JP Morgan, Merrill Lynch, Morgan Stanley, Natixis Securities, Needham, Standard & Poors, Stanford Financial, Wachovia Securities

Mylan Labs Inc. ShareCast News

Impairment charge harms Mylan 09-May-2008 ShareCast

Mylan Labs Inc. Top Newspaper Links

Mylan and Perrigo win FDA OK to market generic Z... 29-Dec-2007 Chicago Tribune
Germany's Merck sells generic drug business to M... 15-May-2007 USA Today
Germany's Merck sells generics unit to Mylan 14-May-2007 Wall Street Journal

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 20 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Mylan Labs Inc. Market Data

Currency US Dollars
Share Price $9.71  
Change Today $0.34
52 Week High $15.40
52 Week Low $5.75
Volume 5,888,503
Shares Issued 304.38m
Market Cap $2,955.48m
Beta 1.04
RiskGrade 487

What The Brokers Say

Strong Buy 11
Buy 3
Neutral 3
Sell 0
Strong Sell 0
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Mylan Labs Inc. Dividends

No dividends found

Trades for --n/a

Time Volume / Share Price
16:01 92,700 @ $9.71
16:01 1,000 @ $9.71
16:00 15,000 @ $9.71
15:59 300 @ $9.75
15:59 500 @ $9.76

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).